» Articles » PMID: 11250725

Nontransgenic Models of Breast Cancer

Overview
Specialty Oncology
Date 2001 Mar 16
PMID 11250725
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous models have been developed to address key elements in the biology of breast cancer development and progression. No model is ideal, but the most useful are those that reflect the natural history and histopathology of human disease, and allow for basic investigations into underlying cellular and molecular mechanisms. We describe two types of models: those that are directed toward early events in breast cancer development (hyperplastic alveolar nodules [HAN] murine model, MCF10AT human xenograft model); and those that seek to reflect the spectrum of metastatic disease (murine sister cell lines 67, 168, 4T07, 4T1). Collectively, these models provide cell lines that represent all of the sequential stages of progression in breast disease, which can be modified to test the effect of genetic changes.

Citing Articles

Identification of intratumoral bacteria that enhance breast tumor metastasis.

Gerbec Z, Serapio-Palacios A, Metcalfe-Roach A, Krekhno Z, Bar-Yoseph H, Woodward S mBio. 2025; 16(3):e0359524.

PMID: 39932300 PMC: 11898647. DOI: 10.1128/mbio.03595-24.


Detecting metastatic potential of cancer through longitudinal vasculature imaging of biomaterial scaffold using non-invasive photoacoustic microscopy and optical coherence tomography.

Xu Z, Escalona G, Schrack I, Zhang W, Zhai T, Shea L Theranostics. 2025; 15(2):509-520.

PMID: 39744684 PMC: 11671391. DOI: 10.7150/thno.101685.


Relatively Rare Populations of Invasive Cells Drive Progression of Heterogeneous Tumors.

Leggett S, Brennan M, Martinez S, Tien J, Nelson C Cell Mol Bioeng. 2024; 17(1):7-24.

PMID: 38435793 PMC: 10902221. DOI: 10.1007/s12195-023-00792-w.


An engineered niche delineates metastatic potential of breast cancer.

Orbach S, DeVaull C, Bealer E, Ross B, Jeruss J, Shea L Bioeng Transl Med. 2024; 9(1):e10606.

PMID: 38193115 PMC: 10771563. DOI: 10.1002/btm2.10606.


Time of day bias for biological sampling in studies of mammary cancer.

Walton J, Walker 2nd W, Nelson R, DeVries A Sci Rep. 2024; 14(1):848.

PMID: 38191908 PMC: 10774401. DOI: 10.1038/s41598-023-50785-y.


References
1.
Shekhar P, Werdell J, Basrur V . Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines. J Natl Cancer Inst. 1997; 89(23):1774-82. DOI: 10.1093/jnci/89.23.1774. View

2.
Miller F, Pauley R, Wang B . Activated c-Ha-ras is not sufficient to produce the preneoplastic phenotype of human breast cell line MCF10AT. Anticancer Res. 1996; 16(4A):1765-9. View

3.
Shekhar P, Chen M, Werdell J, Heppner G, Miller F, Christman J . Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancer. Int J Oncol. 1998; 13(5):907-15. DOI: 10.3892/ijo.13.5.907. View

4.
Neri A, Welch D, Kawaguchi T, Nicolson G . Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst. 1982; 68(3):507-17. View

5.
SOULE H, Maloney T, WOLMAN S, PETERSON Jr W, Brenz R, McGrath C . Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 1990; 50(18):6075-86. View